COSMO Wave 2.6
Prevalence of and experiences with long-COVID, and the use of public health measures while sick and barriers to staying home
Impact Canada, Impact & Innovation Unit, Privy Council Office
Key Insights
Proximity to COVID-19 & Public Health Measures: 58% of respondents reported having been - or likely having been - infected with COVID-19 at some point in the pandemic (up from 31% in June, 49% in August and 54% in October) and 13% of those who have been infected reported having experienced symptoms of Post-COVID-19 Condition. A third of respondents reported having been sick with a fever, cough, sore throat or runny nose in the past month. Among those who were sick, half reported wearing a mask while sick and three quarters stayed home when sick.
Adult Vaccination: Among respondents with 2 doses of a COVID-19 vaccine, top reported reasons for not having gotten a 3rd dose so far were linked to: concern about side effects or not wanting to feel sick after getting the vaccine; the perception that vaccines are ineffective, that they are not curbing the spread of COVID-19 and that people are still contracting COVID after vaccination; and the perception that another dose is not needed.
Pediatric Vaccination: The top reasons provided by parents who had not yet vaccinated at least one of their children were: worries about side effects of the vaccine; the view that children are not at risk from COVID-19; the perception that vaccines were insufficiently tested; and the perception that vaccines are ineffective.
Sources of Information & Trust: Trust in information sources for COVID-19 has not shifted significantly since data collection began. 51% of respondents reported completely or moderately trusting the Canadian federal government, while 37% reported moderate or complete distrust. News consumption about COVID-19 decreased between April and June 2022 and remained low in subsequent months.
COVID-19 Knowledge & Misinformation: Large portions of the sample indicated uncertainty about the accuracy of true statements about COVID-19 – suggesting that there are knowledge gaps on COVID-19 information. A minority of respondents indicated that false statements about COVID-19 were ‘very accurate’ or ‘somewhat accurate’.
Mental Health & Wellbeing: Life satisfaction decreased slightly between August and October and remained stable in December. Younger respondents (18-34) reported lower life satisfaction and poorer mental health indicators than to older respondents.
Pandemic Outlook & Recovery: Over half of the sample (55%) indicated that the worst of the COVID-19 crisis is behind us. One third indicated that day-to-day life currently resembles pre-pandemic times, while one third indicated that life will never resemble pre-pandemic times. Over time, most of respondents’ health-related worries have declined, with the exception of worry about healthcare systems being overloaded, which has increased. Compared to worries about COVID-19, worries about inflation, increasing divisiveness in society and climate change are higher priority.
Background
From April 2020 to November 2021, Impact Canada led the implementation of the World Health Organization (WHO) Behavioural Insights (BI) Tool on COVID-19 in the Canadian context. This study - COVID-19 Snapshot Monitoring (COSMO Canada) - was conducted in collaboration with the Public Opinion Research Team at the Privy Council Office and the Public Health Agency of Canada. Insights from COSMO Phase One informed the federal response to COVID-19 and enabled whole-of-government decision making to meet the specific, changing needs of citizens throughout the pandemic.
In February 2022, Impact Canada launched the second phase and will continue to monitor the evolving pandemic response context with a new sample of Canadians and a new Advisory Committee.
Methodology
With a longitudinal design, the study follows 2,000 participants recruited from an online panel over eight waves of data collection. Respondents are a representative mix of Canadian adults aged 18 years and older and results are weighted using 2016 Statistics Canada census data to mirror the population distribution in Canada. For more information on the study methodology, please visit the COSMO Canada pre-registration page .
Considerations
Data Collected:
November 22 to December 15, 2022
Sample Size:
1,886
When interpreting the COSMO results, it is useful to keep in mind the context of the data collection period, which may have influenced the responses of survey participants. Prior to and during the Wave 2.6 data collection period:
- Most Canadians were vaccinated. As of December 4, 2022, approximately 90% of the Canadian population aged 18+ had received at least one dose of a COVID-19 vaccine, 89% had at least two doses, 60% had at least three doses, and 27% had four doses. As of January 1, 2023, 29% of adult Canadians completed their primary series or received a booster dose in the past 6 months.
- Among children aged 12-17, 84% had at least one dose, 80% had at least two doses, and 18% had three doses. Among children aged 5-11, 53% had at least one dose, 41% had two doses, and 6% had three doses. 8% of children four and under had one dose and 4% had two doses.
- On October 7, Health Canada authorized the Pfizer COVID-19 bivalent vaccine targeting the Omicron BA.4/BA.5 subvariants. The Moderna bivalent vaccine targeting the Omicron BA.1 subvariant was approved in early September.
- During the data collection period, there was significant news coverage on the healthcare system being overwhelmed with cases of the flu, COVID-19, and RSV.